Ciarambino T, Menna G, Sansone G, Giordano M. Cardiomyopathies: an overview. Int J Mol Sci. 2021. https://doi.org/10.3390/ijms22147722. (MDPI)
Maron BJ, Maron MS. Hypertrophic cardiomyopathy. Lancet. 2013. https://doi.org/10.1016/S0140-6736(12)60397-3. (Elsevier B.V)
Weintraub RG, Semsarian C, Macdonald P. Dilated cardiomyopathy. Lancet. 2017. https://doi.org/10.1016/S0140-6736(16)31713-5. (Lancet Publishing Group)
Wilkinson JD, Landy DC, Colan SD, Towbin JA, Sleeper LA, Orav EJ, Lipshultz SE. The pediatric cardiomyopathy registry and heart failure: key results from the first 15 years. Heart Fail Clin. 2010. https://doi.org/10.1016/j.hfc.2010.05.002.
Harmon WG, Sleeper LA, Cuniberti L, Messere J, Colan SD, Orav EJ, Lipshultz SE. treating children with idiopathic dilated cardiomyopathy (from the Pediatric Cardiomyopathy Registry). Am J Cardiol. 2009;104(2):281–6. https://doi.org/10.1016/j.amjcard.2009.03.033.
Article PubMed PubMed Central Google Scholar
Lee TM, Hsu DT, Kantor P, Towbin JA, Ware SM, Colan SD, Lipshultz SE. Pediatric cardiomyopathies. Circ Res. 2017;121(7):855–73. https://doi.org/10.1161/CIRCRESAHA.116.309386.
Article CAS PubMed PubMed Central Google Scholar
Tariq M. Importance of genetic evaluation and testing in pediatric cardiomyopathy. World J Cardiol. 2014;6(11):1156. https://doi.org/10.4330/wjc.v6.i11.1156.
Article PubMed PubMed Central Google Scholar
Towbin JA. Inherited cardiomyopathies. Circ J. 2014;78(10):2347–56. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467885
Van Sligtenhorst I, Ding ZM, Shi ZZ, Read RW, Hansen G, Vogel P. Cardiomyopathy in α-kinase 3 (Alpk3)-deficient mice. Vet Pathol. 2012;49(1):131–41. https://doi.org/10.1177/0300985811402841.
Article CAS PubMed Google Scholar
Herkert JC, Verhagen JMA, Yotti R, Haghighi A, Phelan DG, James PA, van de Laar IMBH. Expanding the clinical and genetic spectrum of ALPK3 variants: phenotypes identified in pediatric cardiomyopathy patients and adults with heterozygous variants. Am Heart J. 2020;225:108–19. https://doi.org/10.1016/j.ahj.2020.03.023.
Article CAS PubMed Google Scholar
Almomani R, Verhagen JMA, Herkert JC, Brosens E, Van Spaendonck-Zwarts KY, Asimaki A, Van De Laar IMBH. Biallelic truncating mutations in ALPK3 cause severe pediatric cardiomyopathy. J Am Coll Cardiol. 2016;67(5):515–25. https://doi.org/10.1016/j.jacc.2015.10.093.
Article CAS PubMed Google Scholar
Çağlayan AO, Sezer RG, Kaymakçalan H, Ulgen E, Yavuz T, Baranoski JF, Gunel M. ALPK3 gene mutation in a patient with congenital cardiomyopathy and dysmorphic features. Cold Spring Harb Mol Case Stud. 2017;3(5). https://doi.org/10.1101/mcs.a001859.
Jaouadi H, Kraoua L, Chaker L, Atkinson A, Delague V, Levy N, Zaffran S. Novel ALPK3 mutation in a Tunisian patient with pediatric cardiomyopathy and facio-thoraco-skeletal features. J Hum Genet. 2018;63(10):1077–82. https://doi.org/10.1038/s10038-018-0492-1.
Article CAS PubMed Google Scholar
Al Senaidi K, Joshi N, Al-Nabhani M, Al-Kasbi G, Al Farqani A, Al-Thihli K, Al-Maawali A. Phenotypic spectrum of ALPK3-related cardiomyopathy. Am J Med Genet A. 2019;179(7):1235–40. https://doi.org/10.1002/ajmg.a.61176.
Article CAS PubMed Google Scholar
Lopes LR, Garcia-Hernández S, Lorenzini M, Futema M, Chumakova O, Zateyshchikov D, Elliott PM. Alpha-protein kinase 3 (ALPK3) truncating variants are a cause of autosomal dominant hypertrophic cardiomyopathy. Eur Heart J. 2021;42(32):3063–73. https://doi.org/10.1093/eurheartj/ehab424.
Article CAS PubMed PubMed Central Google Scholar
Li L, Bainbridge MN, Tan Y, Willerson JT, Marian AJ. A potential oligogenic etiology of hypertrophic cardiomyopathy: a classic single-gene disorder. Circ Res. 2017;120(7):1084–90. https://doi.org/10.1161/CIRCRESAHA.116.310559.
Article CAS PubMed PubMed Central Google Scholar
Agarwal R, Wakimoto H, Paulo JA, Zhang Q, Reichart D, Toepfer C, Seidman CE. Pathogenesis of cardiomyopathy caused by variants in ALPK3, an essential pseudokinase in the cardiomyocyte nucleus and sarcomere. Circulation. 2022. https://doi.org/10.1161/circulationaha.122.059688.
Comments (0)